🏥 治験ポータル
← 治験一覧に戻る

慢性期脳卒中患者に対する脳内自家幹細胞療法

基本情報

NCT ID
NCT06752720
ステータス
募集中
試験のフェーズ
第2相
試験タイプ
介入
目標被験者数
8
治験依頼者名
Hokkaido University Hospital

概要

The goal of this clinical trial is to evaluate if autologous mesenchymal stem cell (HUNS001-01) transplantation therapy can provide neurological recovery in patients with chronic stage of stroke resulting in moderate to severe neurological sequelae. The main questions it aims to answer are: Can HUNS001-01 intracerebral transplantation demonstrate improvement in the mRS of disability for 1 year after intervention? Can HUNS001-01 intracerebral transplantation can be performed without any adverse events for 1 year after intervention? Participants will receive the below interventions. * Screening for the eligibility to enroll the clinical trial (interview, blood test, imaging) * Harvest of platelet concentrates (PC) * Harvest of bone marrows (BM) * Receive intracerebral transplantation surgery of HUNS001-01 * Post-operative rehabilitation * Follow-up studies (until 1 year or termination of the trial)

対象疾患

StrokeStroke, IschemicStroke; Sequelae

介入

Stem cell Transplantation(DRUG)

依頼者(Sponsor)

実施施設 (1)

北海道大学病院

Sapporo, Hokkaido, Japan(RECRUITING)